Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Lirio will host two days of in-booth sessions during the event, featuring experts from our AI and behavioral science teams, and we look forward to meeting with healthcare executives from around the country to discuss the biggest challenges and opportunities they’re facing.
COVID-19 affects everyone, but harmfully affects people with diabetes, which caused many to delay care during the pandemic. Learn about Lirio’s innovative Precision Nudging solution built to help diabetes patients resume care and remain digitally engaged in between appointments.
Lirio, whose Precision Nudging™ solution promotes health through AI-powered behavior change, today announced the launch of a new Precision Nudging™ solution to help people with diabetes receive recommended health care. The solution was co-developed with Bon Secours Mercy Health (BSMH), one of the 20 largest hospital systems in the United States, to close gaps in diabetes care and improve the health of the diabetes community it serves.
Learn how health systems can use ingroup/outgroup bias to improve patient engagement and move patients to healthier behaviors.
COVID-19 launched an explosion of digital health solutions aimed at making patient care more personalized, convenient, and effective. Learn how behavior change AI supports patient-centered care.
Lirio, whose Precision Nudging™ solution improves health outcomes through AI-powered behavior change, has named Marten den Haring as new chief executive officer. As part of an executive transition, Mike West, who has served as Lirio’s CEO since 2018, will continue to lead the board as executive chairman.